Presentation is loading. Please wait.

Presentation is loading. Please wait.

David N. Juurlink, et al. CMAJ 2009;180: (7) [Epub]

Published byIsabelle Holyoak Modified over 9 years ago

Similar presentations

Presentation on theme: "David N. Juurlink, et al. CMAJ 2009;180: (7) [Epub]"— Presentation transcript:

1 David N. Juurlink, et al. CMAJ 2009;180: (7) [Epub]

2 Study design David N. Juurlink, et al. CMAJ 2009;180: (7) [Epub]

3 Characteristics of study patients David N. Juurlink, et al. CMAJ 2009;180: (7) [Epub]

4 Association between acid-reducing therapies and adverse outcomes David N. Juurlink, et al. CMAJ 2009;180: (7) [Epub]

5 Association between exposure to proton pump inhibitors and recurrent myocardial infarction among patients who started taking clopidogrel following index myocardial infarction David N. Juurlink, et al. CMAJ 2009;180: (7) [Epub]

6 Drug covariates used in the multivariable model David N. Juurlink, et al. CMAJ 2009;180: (7) [Epub]

Download ppt "David N. Juurlink, et al. CMAJ 2009;180: (7) [Epub]"

Similar presentations

KAVITHA KANAKANTI.  To confirm the number of patients who were on Clopidogrel are taking Proton Pump Inhibitors.

KAVITHA KANAKANTI.  To confirm the number of patients who were on Clopidogrel are taking Proton Pump Inhibitors.
Description of Each Study in the Cross Trial Safety Analysis Solomon SD, et al. Circulation 2008 [Epub Mar 31]

Description of Each Study in the Cross Trial Safety Analysis Solomon SD, et al. Circulation 2008 [Epub Mar 31]
Www.aodhealth.org1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence May–June 2010.

Journal Club Alcohol, Other Drugs, and Health: Current Evidence May–June 2010.
Journal Club DR.ZEESHAN TARIQ PGY 1. Clinical Scenario A 69 years old male is getting discharged from the hospital where he was admitted for an acute.

Journal Club DR.ZEESHAN TARIQ PGY 1. Clinical Scenario A 69 years old male is getting discharged from the hospital where he was admitted for an acute.
Cardiovascular Outcomes and Mortality in Patients Using Clopidogrel With Proton Pump Inhibitors After Percutaneous Coronary Intervention or Acute Coronary.

Cardiovascular Outcomes and Mortality in Patients Using Clopidogrel With Proton Pump Inhibitors After Percutaneous Coronary Intervention or Acute Coronary.
Nilofar Rahman, MD RISK OF RECURRENCE OF CLOSTRIDIUM DIFFICILE INFECTION WITH PPI USE.

Nilofar Rahman, MD RISK OF RECURRENCE OF CLOSTRIDIUM DIFFICILE INFECTION WITH PPI USE.
Ho PM, et al. JAMA 2009;301:937-44. Baseline Characteristics of Patients Taking Clopidogrel After Hospital Discharge a Ho PM, et al. JAMA 2009;301:937-44.

Ho PM, et al. JAMA 2009;301: Baseline Characteristics of Patients Taking Clopidogrel After Hospital Discharge a Ho PM, et al. JAMA 2009;301:
INTRODUCTION Dual antiplatelet therapy is a cornerstone of medical therapy for patients undergoing percutaneous coronary intervention (PCI) for coronary.

INTRODUCTION Dual antiplatelet therapy is a cornerstone of medical therapy for patients undergoing percutaneous coronary intervention (PCI) for coronary.
Hideki Shimomura, MD* 1 ; Seiji Hokimoto, MD* 2 ; Shuichi Oshima, MD* 3 ; Koichi Nakao, MD* 4 ; Yuji Miyao, MD* 5 ; Hisao Ogawa, MD* 2 ; for the Kumamoto.

Hideki Shimomura, MD* 1 ; Seiji Hokimoto, MD* 2 ; Shuichi Oshima, MD* 3 ; Koichi Nakao, MD* 4 ; Yuji Miyao, MD* 5 ; Hisao Ogawa, MD* 2 ; for the Kumamoto.
David J. Graham et al. JAMA, 2004; 292: 2585 Description of Inception Cohorts for Patients Using Statin and Fibrate Drug Therapy.

David J. Graham et al. JAMA, 2004; 292: 2585 Description of Inception Cohorts for Patients Using Statin and Fibrate Drug Therapy.
The ACTIVE Investigators. N Engl J Med 2009 Apr 3 [Epub]

The ACTIVE Investigators. N Engl J Med 2009 Apr 3 [Epub]
Patient disposition Dichtl W, et al. Am J Cardiol. 2008;102:743-8 AVR = aortic valve replacement; MDCT = multidetector computed tomographic.

Patient disposition Dichtl W, et al. Am J Cardiol. 2008;102:743-8 AVR = aortic valve replacement; MDCT = multidetector computed tomographic.
Baseline Characteristics of Patients Referred for Stress Myocardial Perfusion Testing by Erectile Function Classification James K. Min, et al, Arch Intern.

Baseline Characteristics of Patients Referred for Stress Myocardial Perfusion Testing by Erectile Function Classification James K. Min, et al, Arch Intern.
Effect of Proton Pump Inhibitors on Clinical Outcome in Patients treated with Clopidogrel: a Meta-Analysis Bernd Jilma, Karsten Schrör, Günter Christ,

Effect of Proton Pump Inhibitors on Clinical Outcome in Patients treated with Clopidogrel: a Meta-Analysis Bernd Jilma, Karsten Schrör, Günter Christ,
Cardiovascular and Gastrointestinal Outcomes in Clopidogrel Users on Proton Pump Inhibitors: Results of a Large Dutch Cohort Study 소화기 내과 R1 박지윤 Ofke S.

Cardiovascular and Gastrointestinal Outcomes in Clopidogrel Users on Proton Pump Inhibitors: Results of a Large Dutch Cohort Study 소화기 내과 R1 박지윤 Ofke S.
Multivariate associations* between selected covariates and statin use Jawahar L. Mehta, et al. Am J Cardiol 2006;98:923–928.

Multivariate associations* between selected covariates and statin use Jawahar L. Mehta, et al. Am J Cardiol 2006;98:923–928.
Hideki Shimomura, MD* 1 ; Seiji Hokimoto, MD* 2 ; Shuichi Oshima, MD* 3 ; Koichi Nakao, MD* 4 ; Yuji Miyao, MD* 5 ; Kazuko Nakagawa, MD* 6 ; Hisao Ogawa,

Hideki Shimomura, MD* 1 ; Seiji Hokimoto, MD* 2 ; Shuichi Oshima, MD* 3 ; Koichi Nakao, MD* 4 ; Yuji Miyao, MD* 5 ; Kazuko Nakagawa, MD* 6 ; Hisao Ogawa,
Discontinuation of medication after nonfatal event: MI

Discontinuation of medication after nonfatal event: MI
ARCTIC-INTERRUPTION 2-year- Versus 1year Duration of Dual-Antiplatelet Therapy After DES implantation The randomized ARCTIC-Interruption Study JP Collet.

ARCTIC-INTERRUPTION 2-year- Versus 1year Duration of Dual-Antiplatelet Therapy After DES implantation The randomized ARCTIC-Interruption Study JP Collet.
Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment:

Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment:

Similar presentations

Ads by Google